Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

NHS image

NHS plans bashed over cancer and heart disease

December 24, 2014 Research and Development, Sales and Marketing Cancer, England, NHS, Simon Stevens, funding, heart

Hundreds of healthcare experts have signed an open letter to NHS chief executive Simon Stevens calling for him to scrap …
News
jonathon-kellerman

Actavis hires senior head from PwC

December 24, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Jonathon Kellerman, pwC

Jonathon Kellerman has joined Ireland-based speciality pharma firm Actavis as its executive vice president and global chief compliance officer.  Reporting …
Appointment
EMA image

EMA ramps up adaptive pathways pilot

December 23, 2014 Manufacturing and Production, Research and Development, Sales and Marketing EMA, adaptive pathways, drugs, regulator

Six medicines have been selected to move to the next stage of the EMA’s adaptive pathways pilot project, to explore …
News

New hope through Ebola vaccine trial

December 23, 2014 Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, US, marburg, uganda

A report in the Lancet medical journal has highlighted a treatment found to be well-tolerated in healthy Ugandan adults during …
News
lionel_goldfrank

New chairman for Egenix

December 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing egenix, lionel goldfrank

Lionel Goldfrank has been elected to sit on the board of the US-based biotech firm Egenix. Goldfrank is to succeed Donald …
Appointment
Ian Goldin, director, Oxford Martin School, University of Oxford speaks at the c

Visions for the future: FT pharma and biotech event

December 19, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, ABPI, Deloitte, Medidata, Whitehead, financial ties, freeman, ft pharma

The FT Global Pharmaceutical and Biotechnology Conference held in London recently asked: “What will the life science company of the …
Feature
andrew_plump_takeda

Takeda takes senior head from Sanofi

December 19, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Takeda, andrew plump

Dr Andrew Plump will be joining Takeda in February from Sanofi to lead its global R&D operations as chief medical …
Appointment

Humira biosimilar released in India

December 18, 2014 Research and Development, Sales and Marketing Humira, India, Zydus Cadila, anti-inflammatory, arthritis, bioscience

Indian firm Zydus Cadila has launched the first biosimilar of AbbVie’s anti-inflammatory medicine Humira, the world’s biggest-selling drug. Used as …
News

Government plans £6 billion precision medicine strategy

December 18, 2014 Research and Development, Sales and Marketing ABPI, Cell Therapy Catapult, Ebola, George Osborne, UK, government

The government has committed to a £6 billion investment in scientific research and development as part of its science and …
News

Lundbeck scraps stroke drug

December 18, 2014 Research and Development, Sales and Marketing AIS, DIAS, Lundbeck, acute ischemic stroke, desmoteplase, stroke

Lundbeck has stopped development of its investigational stroke drug desmoteplase following disappointing results from its Phase III studies. The DIAS-3 …
News
bernard_poussot_roche

Roche adds two to its board

December 18, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernard Poussot, Richard Lift, Roche, Sanofi

Roche intends to grow at its March annual general meeting via the election of Bernard Poussot and Richard Lift who …
Appointment
research image

Big pharma spent $112 billion on R&D in 2013

December 17, 2014 Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research

The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …
News
EMA image

Adaptive licensing could ‘transform industry’

December 17, 2014 Research and Development, Sales and Marketing Clinical Pharmacology & Therapeutics, EFPIA, EMA, MHRA, adaptive licesning

Drug regulators should switch to adaptive pathways as the preferred approach to bringing future new medicines to patients, according to …
News
GSK image

GSK Ebola vaccine gets EU support

December 17, 2014 Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …
News
Stevenage Bioscience Catalyst campus image

Cell Therapy Catapult to build £55 million bioscience campus

December 17, 2014 Research and Development, Sales and Marketing Cell Therapy Catapult, UK, bioscience, research, stevenage

UK firm The Cell Therapy Catapult has chosen to build a £55 million state-of-the-art cell therapy manufacturing centre in Stevenage. …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025